Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Rebecca Schnepf & Oliver Zolk. (2013) Effect of the ATP-binding cassette transporter ABCG2 on pharmacokinetics: experimental findings and clinical implications. Expert Opinion on Drug Metabolism & Toxicology 9:3, pages 287-306.
Read now
Read now
Olivier Fardel, Elise Kolasa & Marc Le Vee. (2012) Environmental chemicals as substrates, inhibitors or inducers of drug transporters: implication for toxicokinetics, toxicity and pharmacokinetics. Expert Opinion on Drug Metabolism & Toxicology 8:1, pages 29-46.
Read now
Read now
Robert Elsby, Veronica Smith, Lisa Fox, David Stresser, Caroline Butters, Pradeep Sharma & Dominic D. Surry. (2011) Validation of membrane vesicle-based breast cancer resistance protein and multidrug resistance protein 2 assays to assess drug transport and the potential for drug–drug interaction to support regulatory submissions. Xenobiotica 41:9, pages 764-783.
Read now
Read now
Anna Brózik, Csilla Hegedüs, Zsuzsa Erdei, Tamás Hegedűs, Csilla Özvegy-Laczka, Gergely Szakács & Balázs Sarkadi. (2011) Tyrosine kinase inhibitors as modulators of ATP binding cassette multidrug transporters: substrates, chemosensitizers or inducers of acquired multidrug resistance?. Expert Opinion on Drug Metabolism & Toxicology 7:5, pages 623-642.
Read now
Read now
Articles from other publishers (19)
Shekoufeh Almasi & Yassine El Hiani. (2020) Exploring the Therapeutic Potential of Membrane Transport Proteins: Focus on Cancer and Chemoresistance. Cancers 12:6, pages 1624.
Crossref
Crossref
Pablo Torres-Vergara, Carlos Escudero & Jeffrey Penny. (2018) Drug Transport at the Brain and Endothelial Dysfunction in Preeclampsia: Implications and Perspectives. Frontiers in Physiology 9.
Crossref
Crossref
Houfu Liu, Liang Huang, Yi Li, Tingting Fu, Xueying Sun, Yan-Yan Zhang, Ruina Gao, Qingfang Chen, Wandong Zhang, Jasminder Sahi, Scott Summerfield & Kelly Dong. (2017) Correlation between Membrane Protein Expression Levels and Transcellular Transport Activity for Breast Cancer Resistance Protein. Drug Metabolism and Disposition 45:5, pages 449-456.
Crossref
Crossref
Marilyn E. Morris & Xiaowen Guan. 2016. Drug Delivery. Drug Delivery
62
102
.
Mark F. Rosenberg, Zsolt Bikadi, Eszter Hazai, Tobias Starborg, Lawrence Kelley, Naomi E. Chayen, Robert C. Ford & Qingcheng Mao. (2015) Three-dimensional structure of the human breast cancer resistance protein (BCRP/ABCG2) in an inward-facing conformation. Acta Crystallographica Section D Biological Crystallography 71:8, pages 1725-1735.
Crossref
Crossref
Sanjay K. Nigam. (2014) What do drug transporters really do?. Nature Reviews Drug Discovery 14:1, pages 29-44.
Crossref
Crossref
Agnès Poirier, Renée Portmann, Anne-Christine Cascais, Urs Bader, Isabelle Walter, Mohammed Ullah & Christoph Funk. (2014) The Need for Human Breast Cancer Resistance Protein Substrate and Inhibition Evaluation in Drug Discovery and Development: Why, When, and How?. Drug Metabolism and Disposition 42:9, pages 1466-1477.
Crossref
Crossref
Yi-Lung Ding, Yu-Hsuan Shih, Fu-Yuan Tsai & Max K. Leong. (2014) In Silico Prediction of Inhibition of Promiscuous Breast Cancer Resistance Protein (BCRP/ABCG2). PLoS ONE 9:3, pages e90689.
Crossref
Crossref
Patricio Godoy, Nicola J. Hewitt, Ute Albrecht, Melvin E. Andersen, Nariman Ansari, Sudin Bhattacharya, Johannes Georg Bode, Jennifer Bolleyn, Christoph Borner, Jan Böttger, Albert Braeuning, Robert A. Budinsky, Britta Burkhardt, Neil R. Cameron, Giovanni Camussi, Chong-Su Cho, Yun-Jaie Choi, J. Craig Rowlands, Uta Dahmen, Georg Damm, Olaf Dirsch, María Teresa Donato, Jian Dong, Steven Dooley, Dirk Drasdo, Rowena Eakins, Karine Sá Ferreira, Valentina Fonsato, Joanna Fraczek, Rolf Gebhardt, Andrew Gibson, Matthias Glanemann, Chris E. P. Goldring, María José Gómez-Lechón, Geny M. M. Groothuis, Lena Gustavsson, Christelle Guyot, David Hallifax, Seddik Hammad, Adam Hayward, Dieter Häussinger, Claus Hellerbrand, Philip Hewitt, Stefan Hoehme, Hermann-Georg Holzhütter, J. Brian Houston, Jens Hrach, Kiyomi Ito, Hartmut Jaeschke, Verena Keitel, Jens M. Kelm, B. Kevin Park, Claus Kordes, Gerd A. Kullak-Ublick, Edward L. LeCluyse, Peng Lu, Jennifer Luebke-Wheeler, Anna Lutz, Daniel J. Maltman, Madlen Matz-Soja, Patrick McMullen, Irmgard Merfort, Simon Messner, Christoph Meyer, Jessica Mwinyi, Dean J. Naisbitt, Andreas K. Nussler, Peter Olinga, Francesco Pampaloni, Jingbo Pi, Linda Pluta, Stefan A. Przyborski, Anup Ramachandran, Vera Rogiers, Cliff Rowe, Celine Schelcher, Kathrin Schmich, Michael Schwarz, Bijay Singh, Ernst H. K. Stelzer, Bruno Stieger, Regina Stöber, Yuichi Sugiyama, Ciro Tetta, Wolfgang E. Thasler, Tamara Vanhaecke, Mathieu Vinken, Thomas S. Weiss, Agata Widera, Courtney G. Woods, Jinghai James Xu, Kathy M. Yarborough & Jan G. Hengstler. (2013) Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Archives of Toxicology 87:8, pages 1315-1530.
Crossref
Crossref
Jörg König, Fabian Müller & Martin F. Fromm. (2013) Transporters and Drug-Drug Interactions: Important Determinants of Drug Disposition and Effects. Pharmacological Reviews 65:3, pages 944-966.
Crossref
Crossref
Florine Lecerf-Schmidt, Basile Peres, Glaucio Valdameri, Charlotte Gauthier, Evelyn Winter, Léa Payen, Attilio Di Pietro & Ahcène Boumendjel. (2013) ABCG2: recent discovery of potent and highly selective inhibitors. Future Medicinal Chemistry 5:9, pages 1037-1045.
Crossref
Crossref
Bruno Stieger & Gerd A. Kullak-Ublick. 2013. Drug-Induced Liver Disease. Drug-Induced Liver Disease
123
133
.
Jochen Maas, Roland Wesch & Dietmar Weitz. 2013. Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays. Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays
1095
1123
.
Katharina Mertsch. 2013. Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays. Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays
745
777
.
Pål Kristian Selbo, Anette Weyergang, Marius Strømbo Eng, Monica Bostad, Gunhild M. Mælandsmo, Anders Høgset & Kristian Berg. (2012) Strongly amphiphilic photosensitizers are not substrates of the cancer stem cell marker ABCG2 and provides specific and efficient light-triggered drug delivery of an EGFR-targeted cytotoxic drug. Journal of Controlled Release 159:2, pages 197-203.
Crossref
Crossref
Atsushi Hosomi, Takeo Nakanishi, Takuya Fujita & Ikumi Tamai. (2012) Extra-Renal Elimination of Uric Acid via Intestinal Efflux Transporter BCRP/ABCG2. PLoS ONE 7:2, pages e30456.
Crossref
Crossref
C. Yan Cheng & Dolores D. Mruk. (2012) The Blood-Testis Barrier and Its Implications for Male Contraception. Pharmacological Reviews 64:1, pages 16-64.
Crossref
Crossref
K Mandery, H Glaeser & MF Fromm. (2011) Interaction of innovative small molecule drugs used for cancer therapy with drug transporters. British Journal of Pharmacology 165:2, pages 345-362.
Crossref
Crossref
Bruno Stieger & Peter J Meier. (2011) Pharmacogenetics of drug transporters in the enterohepatic circulation. Pharmacogenomics 12:5, pages 611-631.
Crossref
Crossref